Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.
Also called NCT06653348
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 2/3
- Enrolled
- 100 participants
- Sponsor
- Mazandaran University of Medical Sciences
- Registry
-
NCT06653348
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Iran
- Registry status
- Recruiting
Technical summary
Registry record NCT06653348. Randomized; single masking; primary purpose prevention. Start 2024-04-01 (actual); primary completion 2026-07-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke
- Acronym
- DEDAPT-TICA
- Condition
- Ischemic Stroke
- Condition
- Transient Ischemic Attack
- Intervention (Drug)
- Ticagrelor 60 + Aspirin
- Intervention (Drug)
- Ticagrelor 90 + aspirin
- Lead sponsor
- Mazandaran University of Medical Sciences
Record details
- Record id
cardio:ct-nct06653348- Content hash
28450b9e9973ddc4ecd3c9e692c43b314466e17bb7bd90a7b295923e583cec07